PLGO carries a strong earnings-beat streak and an attractive valuation into a bullish breakout, but the engine has already downgraded it after price reached its analyst target, and weak growth still weighs on the score.
Thesis pillars
- Earnings Beat Streak Rising Estimates→Stable
- Attractive Valuation→Stable
- Analyst Target Reached Limited Upside→Stable
- +2 more pillars — see the Why tab for full reasoning
Pelagos Insurance Capital Limit (PLGO) Stock Analysis
Catalyst-Driven edge
Financial Services · Insurance - Diversified
Hold if already holding. Not a fresh buy at $25.58, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (2.3% away).
Pelagos Insurance Capital Limited provides insurance and reinsurance solutions in Bermuda, the Republic of Ireland, and the United Kingdom. It operates in two segments: Insurance and Reinsurance. The Insurance segment offers property, marine, asset backed finance and portfolio... Read more
Hold if already holding. Not a fresh buy at $25.58, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (2.3% away). Chart setup: No clear chart pattern; technical signals are mixed. Multiple concerning factors. Consider reducing position. | News modifier +2 (SELL_IF_HOLDING → HOLD_IF_HOLDING) Score 5.2/10, moderate confidence.
Passes 5/7 gates (clean insider activity, no SEC red flags, earnings proximity 18d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: aggressive.
Recent developments
updated 2026-07-25Recent Developments — Pelagos Insurance Capital Limit
Latest news
- NEWS Pelagos Insurance Capital price target raised to $29 from $28 at UBS - TipRanks — TipRanks positive
- NEWS Pelagos Insurance Capital price target raised to $29 from $28 at Keefe Bruyette - TipRanks — TipRanks positive
- NEWS Pelagos Insurance Capital price target raised to $24 from $22 at Barclays - TipRanks — TipRanks neutral
- NEWS PLGO Maintained by Barclays -- Price Target Raised to $24.00 - GuruFocus — GuruFocus positive
- NEWS Zacks Industry Outlook Highlights Oscar Health, Radian, CNO Financial, Pelagos Insurance Capital and Horace Mann Educato — TradingView neutral
Generated 2026-07-25T14:12:24Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Revenue shrinking — -7.3% YoY. Growth thesis broken unless recovery story develops.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $25.58, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (2.3% away). Chart setup: No clear chart pattern; technical signals are mixed. Multiple concerning factors. Consider reducing position. | News modifier +2 (SELL_IF_HOLDING → HOLD_IF_HOLDING) Target $25.66 (+0.3%), stop $24.14 (−6.0%), A.R:R -1.8:1. Score 5.2/10, moderate confidence.
Take-profit target: $25.66 (-12.5% upside). Target $25.66 (+0.3%), stop $24.14 (−6.0%), A.R:R -1.8:1. Stop-loss: $24.14.
Analyst target reached - limited upside remaining; Near 52-week high (2.3% away); Weak growth.
Pelagos Insurance Capital Limit trades at a P/E of 7.0 (forward 6.3). TrendMatrix value score: 8.4/10. Verdict: Hold.
16 analysts cover PLGO with a consensus score of 3.6/5. Average price target: $26.
What does Pelagos Insurance Capital Limit do?Pelagos Insurance Capital Limited provides insurance and reinsurance solutions in Bermuda, the Republic of Ireland, and...
Pelagos Insurance Capital Limited provides insurance and reinsurance solutions in Bermuda, the Republic of Ireland, and the United Kingdom. It operates in two segments: Insurance and Reinsurance. The Insurance segment offers property, marine, asset backed finance and portfolio credit, aviation and aerospace, political risk, violence and terror, energy, cyber, and other insurance risks products. The Reinsurance segment provides property, retrocession, and whole account reinsurance solutions. The company was formerly known as Fidelis Insurance Holdings Limited and changed its name to Pelagos Insurance Capital Limited in May 2026. Pelagos Insurance Capital Limited was incorporated in 2014 and is headquartered in Pembroke, Bermuda.